Detalhe da pesquisa
1.
Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments.
Value Health
; 18(5): 663-72, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26297095
2.
Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future.
Healthcare (Basel)
; 9(12)2021 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34946448
3.
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Expert Rev Pharmacoecon Outcomes Res
; 21(4): 527-540, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535841
4.
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab.
Appl Health Econ Health Policy
; 18(1): 5-16, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696433
5.
Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future.
Hosp Pract (1995)
; 48(2): 51-67, 2020 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32196395
6.
Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future.
Front Pharmacol
; 11: 108, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32265688
7.
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
Expert Rev Pharmacoecon Outcomes Res
; 19(3): 251-261, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30696372
8.
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Front Public Health
; 6: 328, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568938
9.
SIGNs of COVID-19: Is evidence contagious?
J R Coll Physicians Edinb
; 52(1): 10-11, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146957
10.
Establishing data-intensive healthcare: the case of Hospital Electronic Prescribing and Medicines Administration systems in Scotland.
J Innov Health Inform
; 23(3): 842, 2016 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28059691
11.
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
Expert Rev Clin Pharmacol
; 8(1): 77-94, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25487078
12.
Meeting the current and future challenges of oncology drug development.
Ecancermedicalscience
; 7: ed21, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24883090
13.
Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe.
Expert Rev Pharmacoecon Outcomes Res
; 15(5): 755-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26368060
14.
Scotland v England deal on prescribed drugs: Scottish Medicines Consortium responds.
BMJ
; 333(7577): 1073; author reply 1073, 2006 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-17110734